| Funding Opportunity ID: |
327721 |
| Opportunity Number: |
RFA-DP-21-002 |
| Opportunity Title: |
Epidemiologic Cohort Study of Interstitial Cystitis |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.283 |
| Eligible Applicants: |
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Additional Information on Eligibility: |
This NOFO is open competition |
| Agency Code: |
HHS-CDC-HHSCDCERA |
| Agency Name: |
Department of Health and Human Services
Centers for Disease Control and Prevention - ERA |
| Posted Date: |
Nov 10, 2020 |
| Close Date: |
Jan 14, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Last Updated Date: |
Nov 10, 2020 |
| Award Ceiling: |
$900,000 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$2,490,000 |
| Expected Number of Awards: |
1 |
| Description: |
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC. |
| Version: |
1 |
|
Published at: November 11, 2020 at 12:45AM
View on Grants.gov
No comments: